| Simone Cidnee-allison Phillips, LCSW | |
|
Nmrtc Okinawa, Psc 482, Fpo, AP 96362 | |
| (484) 895-5915 | |
| Not Available |
| Full Name | Simone Cidnee-allison Phillips |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | Nmrtc Okinawa, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003371881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
| 1041C0700X | Social Worker - Clinical | CW021037 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Simone Cidnee-allison Phillips, LCSW Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Ph: () - | Simone Cidnee-allison Phillips, LCSW Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Ph: (484) 895-5915 |
News Archive
There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for Prostate Cancer) suggests that screening reduced prostate cancer deaths, the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found that regular screening does not reduce the cancer death rates in prostate cancer. Researchers thus looked at the actual picture as to which of these – ERSPC or PLCO are correct.
Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption.
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement. Under the terms of the loan, the Company sold promissory notes in the aggregate principal amount of $1.0 million and issued warrants to purchase an aggregate of approximately 1.1 million shares of the Company's common stock at $1.02 per share to certain accredited investors.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
› Verified 8 days ago
Alicia Frisbee, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 561 Box 7481, Fpo, AP 96310 Phone: 805-915-8087 | |
Ms. Patricia L May-awaya, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Box 2927, Fpo, AP 96362 Phone: 816-116-342747 Fax: 816-116-342748 | |
Charu Stokes-williams, LICSW, BCD, PHD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 14010, Fpo, AP 96543 Phone: 671-366-5125 | |
Kevin Ahn, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5171 | |
Ms. Deborah J Kelling, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 2996, Fpo, AP 96362 Phone: 503-895-2716 | |
Makiko Clark, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1645, Fpo, AP 96350 Phone: 315-243-5171 |